The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II study of neoadjuvant high-dose ifosfamide with concurrent radiotherapy followed by surgical resection in high-risk soft tissue sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study.
Xavier Garcia del Muro
No relevant relationships to disclose
Antonio Lopez-Pousa
No relevant relationships to disclose
Maria Jose Flor
No relevant relationships to disclose
Andrés Redondo
No relevant relationships to disclose
Josefina Cruz Jurado
No relevant relationships to disclose
Raquel Andres
No relevant relationships to disclose
Antonio Casado
No relevant relationships to disclose
Joaquin Fra
No relevant relationships to disclose
Jose A. Lopez-Martin
No relevant relationships to disclose
Juan Maurel
No relevant relationships to disclose
Claudia María Valverde
No relevant relationships to disclose
Oscar Gallego
No relevant relationships to disclose
Jose Antonio Narvaez
No relevant relationships to disclose
Silvia Bague
No relevant relationships to disclose
Xavier Sanjuan
No relevant relationships to disclose
Juan M Vinyals
No relevant relationships to disclose